Global Retirement Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$14.5K Buy
174
+40
+30% +$3.29K ﹤0.01% 2250
2024
Q3
$9.8K Sell
134
-107
-44% -$8.04K ﹤0.01% 2303
2024
Q2
$16.5K Sell
241
-524
-68% -$36.3K ﹤0.01% 2084
2024
Q1
$52.9K Sell
765
-496
-39% -$34.1K ﹤0.01% 1390
2023
Q4
$85.1K Sell
1,261
-492
-28% -$28.3K ﹤0.01% 1125
2023
Q3
$89.2K Buy
1,753
+213
+14% +$12.4K ﹤0.01% 985
2023
Q2
$97.5K Hold
1,540
﹤0.01% 964
2023
Q1
$97.4K Buy
1,540
+1,500
+3,750% +$72.5K 0.01% 929
2022
Q4
$2.12K Hold
40
﹤0.01% 2344
2022
Q3
$2K Hold
40
﹤0.01% 2339
2022
Q2
$2K Hold
40
﹤0.01% 2305
2022
Q1
$2K Buy
+40
New +$2.08K ﹤0.01% 2271
2021
Q4
Sell
-863
Closed -$32K 1892
2021
Q3
$32K Hold
863
﹤0.01% 1023
2021
Q2
$35K Sell
863
-41
-5% -$1.52K ﹤0.01% 1002
2021
Q1
$31K Buy
904
+12
+1% +$416 ﹤0.01% 969
2020
Q4
$28K Buy
892
+37
+4% +$972 ﹤0.01% 933
2020
Q3
$22K Buy
855
+113
+15% +$2.58K ﹤0.01% 898
2020
Q2
$19K Buy
742
+283
+62% +$5.73K ﹤0.01% 921
2020
Q1
$7K Sell
459
-49
-10% -$1.06K ﹤0.01% 1146
2019
Q4
$17K Sell
508
-427
-46% -$5.13K ﹤0.01% 1007
2019
Q3
$7K Buy
+935
New +$8.96K ﹤0.01% 1223

Other funds holding ITCI

Global Retirement Partners's ITCI Position: Q4 2024 in Review

Global Retirement Partners increased its Intra-Cellular Therapies Inc. (ITCI) stake by 30% in Q4 2024, buying an estimated $3.29K and bringing the position to 174 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

Global Retirement Partners first reported a position in ITCI in Q3 2019 and has held it in 21 quarters since. The position peaked at $97.5K in Q2 2023. 387 funds tracked by Wall St. Rank hold ITCI as of Q4 2024.

  • Global Retirement Partners held 174 shares of Intra-Cellular Therapies Inc. worth $14.5K as of Q4 2024.
  • Global Retirement Partners bought 40 Intra-Cellular Therapies Inc. shares in Q4 2024, an estimated $3.29K.
  • Intra-Cellular Therapies Inc. made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2024, its #2250 holding.
  • Global Retirement Partners first reported a position in Intra-Cellular Therapies Inc. in Q3 2019 and has held it in 21 quarters since.
  • Global Retirement Partners's Intra-Cellular Therapies Inc. position peaked at $97.5K in Q2 2023.
  • 387 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.